Back
Beam Therapeutics Stock Price Chart

Major Market Shift - Act Now Before it's Too Late
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50
BEAM
Beam Therapeutics
Last Price:
$19.53
Seasonality Move:
23.97%
7 Day Trial
ALL ACCESS PASS
$
7

This tech company grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and BEAM is experiencing selling pressure, which indicates risk of future bearish movement.
Beam Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.48 | Buy |
20-day SMA: | 17.54 | Buy |
50-day SMA: | 23.08 | Sell |
200-day SMA: | 25.09 | Sell |
8-day EMA: | 18.73 | Buy |
20-day EMA: | 18.82 | Buy |
50-day EMA: | 21.36 | Sell |
200-day EMA: | 24.72 | Sell |
Beam Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.9 | Sell |
Relative Strength Index (14 RSI): | 50.24 | Buy |
Chaikin Money Flow: | -678502 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.77 - 21.45) | Buy |
Bollinger Bands (100): | (20.49 - 29.15) | Sell |
Beam Therapeutics Technical Analysis
Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Beam Therapeutics Stock
Is Beam Therapeutics Stock a Buy?
-
Beam Therapeutics share price is 19.52 while BEAM 8-day simple moving average is 18.48, which is a Buy signal.
-
The stock price of BEAM is 19.52 while Beam Therapeutics 20-day SMA is 17.54, which makes it a Buy.
-
Beam Therapeutics 50-day simple moving average is 23.08 while BEAM share price is 19.52, making it a Sell technically.
-
BEAM stock price is 19.52 and Beam Therapeutics 200-day simple moving average is 25.09, creating a Sell signal.
BEAM Technical Analysis vs Fundamental Analysis
Sell
50
Beam Therapeutics (BEAM)
is a Sell
Is Beam Therapeutics a Buy or a Sell?
-
Beam Therapeutics stock is rated a SellThe current Beam Therapeutics [BEAM] share price is $19.52. The Score for BEAM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Beam Therapeutics Stock Info
Market Cap:
1.6B
Price in USD:
19.52
Share Volume:
1.2M
Beam Therapeutics 52-Week Range
52-Week High:
35.25
52-Week Low:
13.53
Sell
50
Beam Therapeutics (BEAM)
is a Sell
Beam Therapeutics Share Price Forecast
-
What is the Beam Therapeutics stock price today?The Beam Therapeutics stock price is 19.52 USD today.
-
Will BEAM stock go up or go down?Beam Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Beam Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Beam Therapeutics is overvalued.
Is Beam Therapeutics Stock a Buy?
-
Beam Therapeutics share price is 19.52 while BEAM 8-day exponential moving average is 18.73, which is a Buy signal.
-
The stock price of BEAM is 19.52 while Beam Therapeutics 20-day EMA is 18.82, which makes it a Buy.
-
Beam Therapeutics 50-day exponential moving average is 21.36 while BEAM share price is 19.52, making it a Sell technically.
-
BEAM stock price is 19.52 and Beam Therapeutics 200-day simple moving average is 24.72, creating a Sell signal.
Fundamental Analysis of Beam Therapeutics
Is Beam Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.02 per share, and an increase next year of $0.05 per share.
Technical Analysis of Beam Therapeutics
Should I short Beam Therapeutics stock?
-
BEAM Moving Average Covergence Divergence (MACD) indicator is -0.9, suggesting Beam Therapeutics is a Sell
-
Beam Therapeutics Relative Strength Index (RSI) is 50.24, which suggest Beam Therapeutics is overbought
-
The Bollinger Bands (25) for Beam Therapeutics is (15.77 - 21.45), which suggest Beam Therapeutics is a Sell
-
The Bollinger Bands (100) for Beam Therapeutics is (20.49 - 29.15), which suggest Beam Therapeutics is a Sell
* Beam Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.